MAPT and Alzheimer disease: The experiments were performed on a recently developed 3xTg-AD mouse model, which is recognised as an extremely relevant, since these transgenic animals show temporal- and region-specific Aβ and tau pathology, which closely resembles that seen in the human AD brain [30], [31].